FR2433M - Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria. - Google Patents

Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria.

Info

Publication number
FR2433M
FR2433M FR918413A FR918413A FR2433M FR 2433 M FR2433 M FR 2433M FR 918413 A FR918413 A FR 918413A FR 918413 A FR918413 A FR 918413A FR 2433 M FR2433 M FR 2433M
Authority
FR
France
Prior art keywords
diethylaminopentyl
dimethoxy
quinoline
amino
malaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR918413A
Other languages
French (fr)
Inventor
Fritz Schoenhoefer
Werner Schulemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR918413A priority Critical patent/FR2433M/en
Application granted granted Critical
Publication of FR2433M publication Critical patent/FR2433M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR918413A 1962-06-23 1962-12-12 Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria. Expired FR2433M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR918413A FR2433M (en) 1962-06-23 1962-12-12 Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR889062A FR1494053A (en) 1962-06-23 1962-06-23 Process for the production of 6-aminoquinolines bearing on nitrogen basic substituents
FR918413A FR2433M (en) 1962-06-23 1962-12-12 Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria.

Publications (1)

Publication Number Publication Date
FR2433M true FR2433M (en) 1964-03-31

Family

ID=8773394

Family Applications (2)

Application Number Title Priority Date Filing Date
FR889062A Expired FR1494053A (en) 1962-06-23 1962-06-23 Process for the production of 6-aminoquinolines bearing on nitrogen basic substituents
FR918413A Expired FR2433M (en) 1962-06-23 1962-12-12 Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR889062A Expired FR1494053A (en) 1962-06-23 1962-06-23 Process for the production of 6-aminoquinolines bearing on nitrogen basic substituents

Country Status (1)

Country Link
FR (2) FR1494053A (en)

Also Published As

Publication number Publication date
FR1494053A (en) 1967-09-08

Similar Documents

Publication Publication Date Title
FR2427M (en) Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders.
FR1837M (en) Medicinal product based on a methylol derivative of β-carboline.
FR2944M (en) Medicine for the treatment of cough based on 2-amino-6-methylheptane.
FR2292M (en) Medicinal product based on a combination of dihydro-ergotamine, caffeine and hydantoin.
FR1974M (en) Medicinal product based on a complex of vitamin b12 and tannin.
FR2869M (en) Medicinal product based on a derivative of cymarin.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR1967M (en) Medicines based on 1,3,4, -thiadiazole derivatives for the treatment of epilepsy.
FR289M (en) Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3323M (en) Medicinal product based on aza-thiaxanthene derivative.
FR1180M (en) Medicinal product based on a derivative of uracyl, intended in particular for the treatment of hyperuricemia and hypercholesterolemia.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR3153M (en) Drug for the treatment of coronary heart disease, based on isopropylidene-2 ', 3' adenosine.
FR3064M (en) Medicines based on aryl-thio-aliphatic compounds for the treatment of atherosclerosis.
FR1638M (en) Composition for the treatment of hemorrhoids, based on adrenalone heparinate.
FR2264M (en) Preparation for the treatment of skin diseases.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.
BE598665A (en) Pharmaceutical preparations for the treatment of leukemia.
FR1284M (en) Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.
FR1174M (en) Medicinal product based on bismuth and sulfanilamide complexes, in particular for the treatment of tonsillitis.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.